Concepts (197)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diethylstilbestrol | 31 | 2026 | 51 | 4.150 |
Why?
|
| Prenatal Exposure Delayed Effects | 29 | 2026 | 155 | 3.840 |
Why?
|
| Estrogens, Non-Steroidal | 18 | 2026 | 38 | 2.020 |
Why?
|
| Breast Neoplasms | 14 | 2026 | 1235 | 1.040 |
Why?
|
| Pregnancy | 40 | 2026 | 2402 | 0.920 |
Why?
|
| Uterine Cervical Neoplasms | 4 | 2024 | 155 | 0.820 |
Why?
|
| Maternal Exposure | 5 | 2019 | 43 | 0.680 |
Why?
|
| Fetal Blood | 5 | 2016 | 73 | 0.650 |
Why?
|
| Mammography | 3 | 2018 | 296 | 0.620 |
Why?
|
| Breast Density | 1 | 2018 | 19 | 0.540 |
Why?
|
| Neoplasms | 5 | 2021 | 1377 | 0.500 |
Why?
|
| Medical Assistance | 1 | 2016 | 10 | 0.500 |
Why?
|
| Culturally Competent Care | 1 | 2016 | 17 | 0.490 |
Why?
|
| Pathology, Clinical | 1 | 2016 | 22 | 0.490 |
Why?
|
| Follow-Up Studies | 14 | 2026 | 2496 | 0.400 |
Why?
|
| Maternal-Fetal Exchange | 3 | 2018 | 32 | 0.390 |
Why?
|
| Sexual Behavior | 3 | 2025 | 192 | 0.390 |
Why?
|
| Gender Identity | 2 | 2025 | 69 | 0.370 |
Why?
|
| Practice Guidelines as Topic | 1 | 2016 | 741 | 0.360 |
Why?
|
| Carcinogens | 3 | 2017 | 33 | 0.360 |
Why?
|
| Risk | 7 | 2021 | 375 | 0.360 |
Why?
|
| Menopause | 3 | 2013 | 257 | 0.350 |
Why?
|
| Mass Screening | 2 | 2016 | 700 | 0.350 |
Why?
|
| Smoking | 2 | 2008 | 864 | 0.350 |
Why?
|
| Pre-Eclampsia | 4 | 2014 | 72 | 0.340 |
Why?
|
| Adult | 30 | 2026 | 17567 | 0.330 |
Why?
|
| Female | 43 | 2026 | 34414 | 0.330 |
Why?
|
| Endocrine Disruptors | 3 | 2025 | 78 | 0.320 |
Why?
|
| Incidence | 8 | 2026 | 1432 | 0.310 |
Why?
|
| Blood Cell Count | 2 | 2016 | 33 | 0.300 |
Why?
|
| Middle Aged | 21 | 2026 | 18491 | 0.290 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2008 | 304 | 0.290 |
Why?
|
| Birth Weight | 2 | 2010 | 83 | 0.280 |
Why?
|
| Autoimmune Diseases | 1 | 2010 | 240 | 0.280 |
Why?
|
| ADP-ribosyl Cyclase 1 | 1 | 2008 | 26 | 0.270 |
Why?
|
| Maternal Welfare | 1 | 2008 | 15 | 0.270 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2008 | 55 | 0.260 |
Why?
|
| Papanicolaou Test | 3 | 2016 | 46 | 0.260 |
Why?
|
| Vaginal Smears | 3 | 2016 | 59 | 0.260 |
Why?
|
| Attitude to Health | 2 | 2015 | 296 | 0.250 |
Why?
|
| Humans | 44 | 2026 | 65826 | 0.250 |
Why?
|
| Environmental Exposure | 1 | 2008 | 228 | 0.230 |
Why?
|
| Breast Diseases | 1 | 2026 | 45 | 0.230 |
Why?
|
| Cohort Studies | 13 | 2020 | 2649 | 0.220 |
Why?
|
| Menstruation Disturbances | 2 | 2018 | 18 | 0.200 |
Why?
|
| Young Adult | 9 | 2025 | 4878 | 0.200 |
Why?
|
| Premature Birth | 2 | 2018 | 116 | 0.200 |
Why?
|
| Case-Control Studies | 4 | 2020 | 1146 | 0.190 |
Why?
|
| Osteoporosis | 2 | 2013 | 113 | 0.180 |
Why?
|
| Menarche | 2 | 2013 | 37 | 0.180 |
Why?
|
| Risk Factors | 10 | 2026 | 5471 | 0.170 |
Why?
|
| Prospective Studies | 5 | 2024 | 3339 | 0.160 |
Why?
|
| Gallbladder Diseases | 1 | 2020 | 26 | 0.160 |
Why?
|
| Surveys and Questionnaires | 11 | 2017 | 2790 | 0.160 |
Why?
|
| Pancreatic Neoplasms | 2 | 2020 | 354 | 0.150 |
Why?
|
| Stem Cells | 2 | 2016 | 278 | 0.150 |
Why?
|
| Infertility, Female | 3 | 2008 | 47 | 0.150 |
Why?
|
| Proportional Hazards Models | 7 | 2026 | 746 | 0.140 |
Why?
|
| Uterine Cervical Dysplasia | 2 | 2016 | 29 | 0.140 |
Why?
|
| Male | 15 | 2025 | 31398 | 0.140 |
Why?
|
| Cardiovascular Diseases | 2 | 2018 | 876 | 0.130 |
Why?
|
| Academic Medical Centers | 2 | 2016 | 309 | 0.130 |
Why?
|
| Volunteers | 1 | 2016 | 17 | 0.130 |
Why?
|
| Medically Uninsured | 1 | 2016 | 46 | 0.120 |
Why?
|
| Medically Underserved Area | 1 | 2016 | 31 | 0.120 |
Why?
|
| Prognosis | 2 | 2018 | 1792 | 0.120 |
Why?
|
| United States | 10 | 2026 | 8190 | 0.120 |
Why?
|
| Age Factors | 5 | 2016 | 1595 | 0.120 |
Why?
|
| Boston | 1 | 2016 | 260 | 0.120 |
Why?
|
| Vulnerable Populations | 1 | 2016 | 95 | 0.120 |
Why?
|
| Cervix Uteri | 1 | 2016 | 58 | 0.120 |
Why?
|
| Genetic Counseling | 1 | 2015 | 16 | 0.110 |
Why?
|
| Genetics, Medical | 1 | 2015 | 10 | 0.110 |
Why?
|
| Vaginal Neoplasms | 1 | 2015 | 4 | 0.110 |
Why?
|
| Fetal Stem Cells | 1 | 2014 | 3 | 0.110 |
Why?
|
| Verbal Behavior | 1 | 2014 | 36 | 0.110 |
Why?
|
| Colposcopy | 1 | 2014 | 20 | 0.110 |
Why?
|
| Adolescent | 7 | 2018 | 6367 | 0.100 |
Why?
|
| Health Communication | 1 | 2014 | 33 | 0.100 |
Why?
|
| Societies, Medical | 1 | 2016 | 401 | 0.100 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2016 | 264 | 0.100 |
Why?
|
| Menstruation | 1 | 2013 | 34 | 0.100 |
Why?
|
| Blood Proteins | 1 | 2013 | 84 | 0.100 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2020 | 736 | 0.100 |
Why?
|
| Parity | 2 | 2015 | 71 | 0.100 |
Why?
|
| Mammary Glands, Human | 1 | 2013 | 56 | 0.100 |
Why?
|
| National Cancer Institute (U.S.) | 2 | 2026 | 37 | 0.090 |
Why?
|
| Umbilical Arteries | 1 | 2012 | 10 | 0.090 |
Why?
|
| Ultrasonography, Doppler | 1 | 2012 | 29 | 0.090 |
Why?
|
| Depression | 1 | 2019 | 910 | 0.090 |
Why?
|
| Pain Management | 1 | 2014 | 174 | 0.090 |
Why?
|
| Fetal Growth Retardation | 1 | 2012 | 22 | 0.090 |
Why?
|
| Aged | 5 | 2026 | 15141 | 0.090 |
Why?
|
| Infant, Newborn | 4 | 2014 | 1441 | 0.090 |
Why?
|
| Pain | 1 | 2014 | 400 | 0.090 |
Why?
|
| Adenocarcinoma | 1 | 2015 | 367 | 0.090 |
Why?
|
| Genital Neoplasms, Female | 1 | 2011 | 18 | 0.090 |
Why?
|
| Proteomics | 1 | 2013 | 299 | 0.090 |
Why?
|
| Fetal Development | 1 | 2010 | 15 | 0.080 |
Why?
|
| Breast | 2 | 2016 | 194 | 0.080 |
Why?
|
| Urogenital Abnormalities | 1 | 2009 | 12 | 0.080 |
Why?
|
| Physicians | 1 | 2015 | 486 | 0.070 |
Why?
|
| Hysterosalpingography | 1 | 2008 | 4 | 0.070 |
Why?
|
| Fallopian Tube Diseases | 1 | 2008 | 6 | 0.070 |
Why?
|
| Exercise | 1 | 2016 | 970 | 0.070 |
Why?
|
| Diabetes Mellitus | 1 | 2013 | 556 | 0.070 |
Why?
|
| Sex Ratio | 1 | 2007 | 11 | 0.070 |
Why?
|
| Genitalia, Male | 1 | 2007 | 11 | 0.070 |
Why?
|
| Risk-Taking | 1 | 2008 | 159 | 0.060 |
Why?
|
| Growth Substances | 1 | 2007 | 34 | 0.060 |
Why?
|
| Pregnancy Complications | 1 | 2011 | 389 | 0.060 |
Why?
|
| Estrogens | 1 | 2007 | 115 | 0.060 |
Why?
|
| Hormones | 1 | 2007 | 62 | 0.060 |
Why?
|
| Estradiol Congeners | 1 | 2006 | 2 | 0.060 |
Why?
|
| Odds Ratio | 4 | 2010 | 757 | 0.060 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2010 | 347 | 0.060 |
Why?
|
| Gestational Age | 3 | 2012 | 196 | 0.060 |
Why?
|
| Uterine Prolapse | 1 | 2005 | 17 | 0.060 |
Why?
|
| Hysterectomy, Vaginal | 1 | 2005 | 14 | 0.060 |
Why?
|
| Adenocarcinoma, Clear Cell | 2 | 2017 | 12 | 0.060 |
Why?
|
| Gynecologic Surgical Procedures | 1 | 2005 | 49 | 0.060 |
Why?
|
| Genitalia | 1 | 2024 | 9 | 0.050 |
Why?
|
| Neoplastic Stem Cells | 1 | 2006 | 196 | 0.050 |
Why?
|
| Disease Susceptibility | 2 | 2014 | 170 | 0.050 |
Why?
|
| Flow Cytometry | 2 | 2016 | 664 | 0.050 |
Why?
|
| Logistic Models | 3 | 2015 | 1274 | 0.050 |
Why?
|
| Functional Laterality | 1 | 2003 | 141 | 0.050 |
Why?
|
| Sex Characteristics | 1 | 2003 | 216 | 0.040 |
Why?
|
| Testicular Neoplasms | 1 | 2001 | 35 | 0.040 |
Why?
|
| Longitudinal Studies | 2 | 2020 | 1291 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2008 | 2113 | 0.040 |
Why?
|
| Early Detection of Cancer | 1 | 2024 | 327 | 0.040 |
Why?
|
| Health Surveys | 2 | 2015 | 319 | 0.040 |
Why?
|
| Child | 3 | 2018 | 4653 | 0.040 |
Why?
|
| Nuclear Family | 2 | 2009 | 18 | 0.040 |
Why?
|
| Reproduction | 1 | 2018 | 100 | 0.030 |
Why?
|
| Sex Factors | 1 | 2001 | 995 | 0.030 |
Why?
|
| Self Report | 1 | 2019 | 395 | 0.030 |
Why?
|
| Endometrial Neoplasms | 1 | 2017 | 77 | 0.030 |
Why?
|
| Mothers | 1 | 2018 | 281 | 0.030 |
Why?
|
| Preconception Care | 1 | 2015 | 23 | 0.030 |
Why?
|
| Knowledge | 1 | 2015 | 33 | 0.030 |
Why?
|
| Animals | 3 | 2010 | 21489 | 0.030 |
Why?
|
| Endothelium, Vascular | 1 | 2016 | 180 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2014 | 211 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2019 | 6953 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 542 | 0.020 |
Why?
|
| Chromatography, Liquid | 1 | 2013 | 119 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2015 | 806 | 0.020 |
Why?
|
| Blood Flow Velocity | 1 | 2012 | 79 | 0.020 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2012 | 50 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2013 | 296 | 0.020 |
Why?
|
| Biomarkers | 1 | 2018 | 1502 | 0.020 |
Why?
|
| Stillbirth | 1 | 2011 | 18 | 0.020 |
Why?
|
| Physician-Patient Relations | 1 | 2015 | 429 | 0.020 |
Why?
|
| Menopause, Premature | 1 | 2011 | 25 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 5681 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2014 | 2194 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2013 | 1029 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2014 | 5830 | 0.020 |
Why?
|
| Abnormalities, Drug-Induced | 1 | 2009 | 14 | 0.020 |
Why?
|
| Cryptorchidism | 1 | 2009 | 21 | 0.020 |
Why?
|
| Fallopian Tube Patency Tests | 1 | 2008 | 2 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2014 | 1583 | 0.020 |
Why?
|
| Urogenital Neoplasms | 1 | 2008 | 5 | 0.020 |
Why?
|
| Health Behavior | 1 | 2011 | 485 | 0.020 |
Why?
|
| Leukemia | 1 | 2008 | 62 | 0.020 |
Why?
|
| Medical Records | 1 | 2008 | 140 | 0.020 |
Why?
|
| Reproductive History | 1 | 2007 | 17 | 0.020 |
Why?
|
| Cesarean Section | 1 | 2008 | 104 | 0.020 |
Why?
|
| Uterus | 1 | 2007 | 41 | 0.020 |
Why?
|
| Infertility, Male | 1 | 2007 | 58 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2007 | 237 | 0.020 |
Why?
|
| Erythroid Precursor Cells | 1 | 2007 | 25 | 0.020 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2007 | 83 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2007 | 498 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2007 | 344 | 0.010 |
Why?
|
| Ligaments | 1 | 2005 | 9 | 0.010 |
Why?
|
| Cell Division | 1 | 2007 | 451 | 0.010 |
Why?
|
| Phosphatidic Acids | 1 | 1983 | 8 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2006 | 414 | 0.010 |
Why?
|
| Phosphatidylinositols | 1 | 1983 | 51 | 0.010 |
Why?
|
| Epigenesis, Genetic | 1 | 2006 | 408 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2008 | 2088 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2008 | 2737 | 0.010 |
Why?
|
| Laparoscopy | 1 | 2005 | 492 | 0.010 |
Why?
|
| Adipose Tissue | 1 | 1983 | 301 | 0.010 |
Why?
|
| Time Factors | 1 | 2007 | 3778 | 0.010 |
Why?
|
| Insulin | 1 | 1983 | 696 | 0.010 |
Why?
|
| Pyruvate Dehydrogenase Complex | 1 | 1983 | 4 | 0.000 |
Why?
|
| Glycogen Synthase | 1 | 1983 | 4 | 0.000 |
Why?
|
| Phosphorus Radioisotopes | 1 | 1983 | 14 | 0.000 |
Why?
|
| Type C Phospholipases | 1 | 1983 | 34 | 0.000 |
Why?
|
| Oxytocin | 1 | 1983 | 44 | 0.000 |
Why?
|
| Adenosine | 1 | 1983 | 79 | 0.000 |
Why?
|
| In Vitro Techniques | 1 | 1983 | 491 | 0.000 |
Why?
|
| Rats | 1 | 1983 | 2005 | 0.000 |
Why?
|